4 years ago

Encouraging long-term outcomes reported in patients with stage I non-small cell lung cancer treated with stereotactic ablative radiotherapy

Mary Kay Barton
At a median of 7.2 years of follow-up, patients with stage I NSCLC who were treated with SABR had outcomes comparable to those noted among patients with stage I disease who were treated with surgery. Research is needed to define whether SABR can be applied to a wider population of patients with NSCLC and how to optimally combine it with systemic therapy.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.3322/caac.21375

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.